3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.

Cancer cells in poorly vascularized tumor regions need to adapt to an unfavorable metabolic microenvironment. As distance from supplying blood vessels increases, oxygen and nutrient concentrations decrease and cancer cells react by stopping cell cycle progression and becoming dormant. As cytostatic drugs mainly target proliferating cells, cancer cell dormancy is considered as a major resistance mechanism to this class of anti-cancer drugs. Therefore, substances that target cancer cells in poorly vascularized tumor regions have the potential to enhance cytostatic-based chemotherapy of solid tumors. With three-dimensional growth conditions, multicellular tumor spheroids (MCTS) reproduce several parameters of the tumor microenvironment, including oxygen and nutrient gradients as well as the development of dormant tumor regions. We here report the setup of a 3D cell culture compatible high-content screening system and the identification of nine substances from two commercially available drug libraries that specifically target cells in inner MCTS core regions, while cells in outer MCTS regions or in 2D cell culture remain unaffected. We elucidated the mode of action of the identified compounds as inhibitors of the respiratory chain and show that induction of cell death in inner MCTS core regions critically depends on extracellular glucose concentrations. Finally, combinational treatment with cytostatics showed increased induction of cell death in MCTS. The data presented here shows for the first time a high-content based screening setup on 3D tumor spheroids for the identification of substances that specifically induce cell death in inner tumor spheroid core regions. This validates the approach to use 3D cell culture screening systems to identify substances that would not be detectable by 2D based screening in otherwise similar culture conditions.

[1]  C. A. Condat,et al.  Quiescent cells: A natural way to resist chemotherapy , 2011 .

[2]  A. Minchinton,et al.  Microregional Effects of Gemcitabine in HCT-116 Xenografts , 2004, Cancer Research.

[3]  G. Mortimer,et al.  Cell proliferation in breast tumours: Analysis of histological parameters Ki67 and PCNA expression , 1993, Irish journal of medical science.

[4]  P. Puigserver,et al.  PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. , 2013, Cancer cell.

[5]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[6]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[7]  H. Lenz,et al.  Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence , 2011, Clinical Cancer Research.

[8]  Juergen Friedrich,et al.  Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.

[9]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[10]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[11]  Takla Griss,et al.  AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. , 2013, Cell metabolism.

[12]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[13]  S. Budd,et al.  Mitochondria and neuronal survival. , 2000, Physiological reviews.

[14]  Simona Ronchi Della Rocca,et al.  λ Δ -Models , 2004 .

[15]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[16]  I. Ben-Sahra,et al.  The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells , 2010, Autophagy.

[17]  H. Esumi,et al.  Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. , 2006, Cancer research.

[18]  I. Ben-Sahra,et al.  The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. , 2010, Autophagy.

[19]  Dario R Alessi,et al.  Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.

[20]  Alastair H Kyle,et al.  Targeting quiescent tumor cells via oxygen and IGF-I supplementation. , 2012, Cancer research.

[21]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[22]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[23]  James P. Freyer,et al.  Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors , 2004, Cancer Research.

[24]  A. Ivascu,et al.  Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.

[25]  P. Verveer,et al.  High-resolution three-dimensional imaging of large specimens with light sheet–based microscopy , 2007, Nature Methods.

[26]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[27]  Paul Jennings,et al.  Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system. , 2011, Molecular bioSystems.

[28]  S. V. Sotirchos,et al.  Glucose diffusivity in multicellular tumor spheroids. , 1988, Cancer research.

[29]  M. Kaminishi,et al.  Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation , 2004, Cancer science.